Acquisition by Big Health Limbix, a pioneer in evidence-based digital therapeutics for teens and young adults, was acquired by Big Health, a leading provider of non-drug mental health treatments. This acquisition opens up potential synergies and cross-selling opportunities within Big Health's existing customer base.

Partnership with Children's Hospital LA The collaboration between Limbix and Children's Hospital Los Angeles to evaluate the SparkRx virtual adolescent depression treatment signifies a strategic opportunity to showcase the effectiveness of Limbix's solutions. This partnership could lead to increased credibility and visibility among other healthcare institutions.

Recognition in CB Insights List Limbix's recognition in the prestigious CB Insights Digital Health 150 List highlights its innovative approach to mental health treatment for adolescents. Being listed as one of the most promising digital health companies globally can act as a powerful sales tool, fostering trust and interest from potential customers and investors.

Launch of Limbix Synapse Platform The launch of the Limbix Synapse platform, an evidence-based digital therapeutics solution for adolescent mental health, presents an ideal opportunity for sales expansion. This platform launch can be leveraged to attract new clients, showcase product innovation, and strengthen market positioning.

Development of SparkRx Digital Therapeutic Limbix's creation of SparkRx, a digital therapeutic offering neurobehavioral interventions for depression in young patients, has significant sales potential. This innovative product can serve as a unique selling point, differentiating Limbix in a competitive mental health care market and attracting customers seeking effective digital treatment options.